BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28199742)

  • 41. Clinical characteristics and outcomes of patients with primary lung adenocarcinoma harboring ALK rearrangements detected by FISH, IHC, and RT-PCR.
    Wang J; Cai Y; Dong Y; Nong J; Zhou L; Liu G; Su D; Li X; Wu S; Chen X; Qin N; Zeng X; Zhang H; Zhang Z; Zhang S
    PLoS One; 2014; 9(7):e101551. PubMed ID: 24992725
    [TBL] [Abstract][Full Text] [Related]  

  • 42. VCL-ALK renal cell carcinoma in children with sickle-cell trait: the eighth sickle-cell nephropathy?
    Smith NE; Deyrup AT; Mariño-Enriquez A; Fletcher JA; Bridge JA; Illei PB; Netto GJ; Argani P
    Am J Surg Pathol; 2014 Jun; 38(6):858-63. PubMed ID: 24698962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of anaplastic lymphoma kinase fusion in clear cell renal carcinoma (ALK-tRCC): a precision oncology medicine case report.
    Varchetta V; Campanella C; Rossi M; Verzaro R; Vitale M; Soda G; Mancuso A
    Recenti Prog Med; 2021 Jan; 112(1):14e-15e. PubMed ID: 33512368
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Immunohistochemistry, fluorescence in situ hybridization, and reverse transcription-polymerase chain reaction for the detection of anaplastic lymphoma kinase gene rearrangements in patients with non-small cell lung cancer: potential advantages and methodologic pitfalls.
    Demidova I; Barinov A; Savelov N; Gagarin I; Grinevitch V; Stroiakovaski D; Popov M; Laktionov K; Gutorov S; Smolin A; Olshanskaya Y; Obukhova T
    Arch Pathol Lab Med; 2014 Jun; 138(6):794-802. PubMed ID: 24878018
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expanding the spectrum of ALK-rearranged renal cell carcinomas in children: Identification of a novel HOOK1-ALK fusion transcript.
    Cajaiba MM; Jennings LJ; George D; Perlman EJ
    Genes Chromosomes Cancer; 2016 Oct; 55(10):814-7. PubMed ID: 27225638
    [No Abstract]   [Full Text] [Related]  

  • 46. Contrast-enhanced ultrasound findings of adult renal cell carcinoma associated with Xp11.2 translocation/TFE3 gene fusion: comparison with clear cell renal cell carcinoma and papillary renal cell carcinoma.
    Wei S; Tian F; Xia Q; Huang P; Zhang Y; Xia Z; Wu M; Yang B
    Cancer Imaging; 2019 Dec; 20(1):1. PubMed ID: 31892340
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinicopathologic and Molecular Analysis of the TFEB Fusion Variant Reveals New Members of TFEB Translocation Renal Cell Carcinomas (RCCs): Expanding the Genomic Spectrum.
    Xia QY; Wang XT; Fang R; Wang Z; Zhao M; Chen H; Chen N; Teng XD; Wang X; Wei X; Ye SB; Li R; Ma HH; Lu ZF; Zhou XJ; Rao Q
    Am J Surg Pathol; 2020 Apr; 44(4):477-489. PubMed ID: 31764220
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities.
    Liu Y; Li X; Fan Y; Xu H; Gu Y; Dong L; Zhou L; Yang X; Wang C
    Heliyon; 2023 Apr; 9(4):e15159. PubMed ID: 37089387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Anaplastic lymphoma kinase (ALK) rearrangement in adult renal cell carcinoma with lung metastasis: a case report and literature review.
    Zhou S; Sun G; Wang J; Zhang H
    Transl Androl Urol; 2020 Dec; 9(6):2855-2861. PubMed ID: 33457258
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Diagnosis of uncommon renal epithelial neoplasms: performances of fluorescence in situ hybridization.
    Beaumont M; Dugay F; Kammerer-Jacquet SF; Jaillard S; Cabillic F; Mathieu R; Verhoest G; Bensalah K; Rioux-Leclercq N; Belaud-Rotureau MA;
    Hum Pathol; 2019 Oct; 92():81-90. PubMed ID: 31437522
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Clinicopathologic and molecular genetic study of renal cell carcinoma occurring in teenagers].
    Rao Q; Zhou J; Zhang RS; Ma HH; Zhou HB; Lu ZF; Zhou XJ
    Zhonghua Bing Li Xue Za Zhi; 2010 Sep; 39(9):582-6. PubMed ID: 21092583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. French multicentric validation of ALK rearrangement diagnostic in 547 lung adenocarcinomas.
    Lantuejoul S; Rouquette I; Blons H; Le Stang N; Ilie M; Begueret H; Grégoire V; Hofman P; Gros A; Garcia S; Monhoven N; Devouassoux-Shisheboran M; Mansuet-Lupo A; Thivolet F; Antoine M; Vignaud JM; Penault-Llorca F; Galateau-Sallé F; McLeer-Florin A
    Eur Respir J; 2015 Jul; 46(1):207-18. PubMed ID: 25929957
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PRCC-TFE3 dual-fusion FISH assay: A new method for identifying PRCC-TFE3 renal cell carcinoma in paraffin-embedded tissue.
    Xiong L; Chen X; Liu N; Wang Z; Miao B; Gan W; Li D; Guo H
    PLoS One; 2017; 12(9):e0185337. PubMed ID: 28949976
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The classification of pediatric and young adult renal cell carcinomas registered on the children's oncology group (COG) protocol AREN03B2 after focused genetic testing.
    Cajaiba MM; Dyer LM; Geller JI; Jennings LJ; George D; Kirschmann D; Rohan SM; Cost NG; Khanna G; Mullen EA; Dome JS; Fernandez CV; Perlman EJ
    Cancer; 2018 Aug; 124(16):3381-3389. PubMed ID: 29905933
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Antibody 1A4 with routine immunohistochemistry demonstrates high sensitivity for ALK rearrangement screening of Chinese lung adenocarcinoma patients: A single-center large-scale study.
    Wang Q; Zhao L; Yang X; Wei S; Zeng Y; Mao C; Lin L; Fu P; Lyu L; Li Z; Xiao H
    Lung Cancer; 2016 May; 95():39-43. PubMed ID: 27040850
    [TBL] [Abstract][Full Text] [Related]  

  • 56. ALK-TPM3 rearrangement in adult renal cell carcinoma: Report of a new case showing loss of chromosome 3 and literature review.
    Bodokh Y; Ambrosetti D; Kubiniek V; Tibi B; Durand M; Amiel J; Pertuit M; Barlier A; Pedeutour F
    Cancer Genet; 2018 Feb; 221():31-37. PubMed ID: 29405994
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Screening of anaplastic lymphoma kinase rearrangement by immunohistochemistry in non-small cell lung cancer: correlation with fluorescence in situ hybridization.
    Paik JH; Choe G; Kim H; Choe JY; Lee HJ; Lee CT; Lee JS; Jheon S; Chung JH
    J Thorac Oncol; 2011 Mar; 6(3):466-72. PubMed ID: 21258247
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Validation and utilization of a TFE3 break-apart FISH assay for Xp11.2 translocation renal cell carcinoma and alveolar soft part sarcoma.
    Pradhan D; Roy S; Quiroga-Garza G; Cieply K; Mahaffey AL; Bastacky S; Dhir R; Parwani AV
    Diagn Pathol; 2015 Sep; 10():179. PubMed ID: 26415891
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinicopathologic implication of ALK rearrangement in surgically resected lung cancer: a proposal of diagnostic algorithm for ALK-rearranged adenocarcinoma.
    Paik JH; Choi CM; Kim H; Jang SJ; Choe G; Kim DK; Kim HJ; Yoon H; Lee CT; Jheon S; Choe JY; Chung JH
    Lung Cancer; 2012 Jun; 76(3):403-9. PubMed ID: 22129856
    [TBL] [Abstract][Full Text] [Related]  

  • 60. ALK gene rearranged lung adenocarcinomas: molecular genetics and morphology in cohort of patients from North India.
    Bal A; Singh N; Agarwal P; Das A; Behera D
    APMIS; 2016 Oct; 124(10):832-8. PubMed ID: 27500967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.